Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Chinese Patients with Relapsed or Refractory Multiple Myeloma: Phase 3 LEPUS (MMY3009) Study.
暂无分享，去创建一个
Xiao-jun Huang | Z. Cai | Jie Jin | Wei Li | Jianda Hu | Z. Ge | M. Qi | Ya-fei Wang | G. An | T. Niu | Jin Lu | C. Fu | W. Fu | Steven Sun | Lijuan Chen | X. Cen | Wenyu Liu | Weiping Liu | Xue Yang | X. Gai | Wenyu Liu | Yafei Wang